Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

This randomized clinical trial assesses whether bimekizumab is efficacious and safe when used to treat patients with hidradenitis suppurativa.
Source: JAMA Dermatology - Category: Dermatology Source Type: research